Headline Partner
Zoetis
Website: https://www.zoetis.com/
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees.
For more information, visit www.zoetis.com
Platinum Sponsor
Elanco
Website: https://www.elanco.com/en-us
Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet.
MSD Animal Health
Website: https://www.msd-animal-health.com/
At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of MSD. Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com and connect with us on LinkedIn and X (formerly Twitter).
Executive Consulting Partner
Stonehaven Cozmix Group
Website: https://www.sc.group/
Stonehaven Cozmix Group (SC Group) is a global life sciences management consultancy firm that serves innovative life sciences companies at various phases of development. The company was created upon the merger of Stonehaven Consulting AG and Cozmix Inc.
Cozmix was founded in 2005 and has successfully advised life science clients in commercial resource allocation with their proprietary tools and software suite. Stonehaven Consulting was established in 2015 and has since then delivered numerous strategy projects for clients in animal health, human health, and private equity.
The merger creates an international leader in life science consulting, focused on commercial strategy and commercial resource allocation where clients can benefit from a broadened service and technology offering, addition expertise, and expanded global presence with offices in Switzerland, UK and USA.
Start-Up Development Partner
Paul Dick and Associates
Website: https://pauldickassociates.com/
Paul Dick & Associates Ltd (PDA) was created in 2010 to meet the needs of large, medium and small animal health companies wishing to develop and commercialize new technologies and products. In 2017, PDA expanded into the human health space to offer its services to companies developing new technologies and services for the human health market.
PDA has a highly experienced team that, in combination with other partner organizations (Contract Research Organizations, Contract Development/ Manufacturing Organizations, Veterinary Colleges, Private Research Facilities), makes for a best in class Human and Animal Health consulting firm.
Senior Event Partners
AskVet
Website: https://askvet.app/
AskVet is the leading AI and data-driven technology company in animal health. We use AI and our proprietary companion animal and livestock data to build highly intelligent veterinary agents that will join the workforce – enhancing engagement, improving efficiency, and supporting revenue growth for animal health organizations.
In 2023, AskVet introduced VERA (Veterinary Engagement & Relationship Agent), the world’s only AI veterinarian. VERA is trained on over 2.5 million recorded conversations between veterinarians and animal owners, curricula from six veterinary colleges, and more than 180 curated medical, nutritional, and behavioral data sets. She currently converses in 50 languages.
As a customizable conversational AI, VERA powers medical triage, operational support, customer acquisition, sales, retention, and back-end automation – making her an invaluable asset across the animal health ecosystem.
Demand in the US for animal health care for both companion animals and food production animals is outpacing supply of qualified veterinarians and technicians. The US animal health industry needs to use data and AI to augment and expand the available supply of human veterinary expertise to close the supply and demand gap. And the problem is much worse if you look at the global growth of companion and food production animals. AskVet has created a suite of data/AI products on the VERA platform where companion and food animal businesses can use their propriety data and VERA’s veterinary expertise to create differentiation and competitive advantage.
Circa Healthcare
Website: https://www.circahealthcare.com/
We’re an Animal-health and Petcare focused, strategic marketing and communications agency. We know there’s no such thing as a ‘normal’ communications challenge. That’s why we unite a unique blend of strategy, collaboration, creativity, and understanding of the Petcare and Animal Healthcare worlds—and everything in them—that you won’t find anywhere else to produce abnormally brilliant results for our clients. It’s not normal. But that’s what we’re all about.
Clinglobal
Website: https://www.clinglobal.com/
Clinglobal is a global, science-based, quality-driven group dedicated to accelerating innovation by providing services and solutions to the animal care industry through the ever-expanding Clinglobal group of companies. Animals are our passion, and people are our strength. Together, we better lives by accelerating animal health innovation.
Our unique business model allows the animal health industry and community to benefit from simplified, comprehensive, and customisable contracting solutions for animal health and nutrition product development and registration.
Our group include companies such as Clinvet (preclinical and lab clinical studies in companion and production animals), Clindata (data management and statistical analysis solutions), Clinomics (molecular biology, clinical pathology and immunology R&D laboratory), rtilab (microbiology and clinical pathology R&D laboratory) and Clinglobal (product development consultancy, regulatory affairs and quality assurance services), as well as an extensive network of strategic partners across geographies and fields of expertise.
Enzene
Website: https://www.enzene.com/
Enzene is an end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA). As a pioneer in next-generation biologics technologies, Enzene is disrupting the existing biologics manufacturing paradigm with its patented EnzeneX™ technology—the first fully-connected continuous manufacturing (FCCM) platform validated for commercial biologics supply. We partner with innovators and biosimilar developers to deliver accelerated time-to-market, increased production yields, and cost reductions across a broad range of biologic modalities. Committed to pushing the boundaries of biologics manufacturing innovation, Enzene is striving to reduce monoclonal antibody production costs to below $40 per gram by 2025.
For more information on Enzene, a subsidiary of Alkem Laboratories Ltd, please visit www.enzene.com
Pet Flavors
Website: https://www.petflavors.com/
PF, Inc. (Pet Flavors, Inc.) is the world leading developer and manufacturer of quality flavor bases for both pharmaceutical drugs and nutritional supplements in the animal health industry. PF Inc. sells several types of flavor bases for use in formulating palatable canine, feline, and equine dosage forms that are sold on a worldwide basis. PF’s Artificial Powdered Beef Flavor; PC-0125 is sold to 9 of the top 10 largest animal health pharmaceutical companies in the world and has been successfully formulated in over 20 New Animal Drug Approvals (NADAs). Our company has over 30 years of experience with formulation and product development. With an active ingredient and our flavor bases we can create highly palatable chewable tablets, soft chews or granules. Our services include improving the palatability of an existing product, creating product line extensions or developing entirely new products. Please visit our website www.petflavors.com for detailed information.
Sidley Austin
Website: https://www.sidley.com/en/eu/
Sidley’s Global Life Sciences practice takes an integrated, multidisciplinary approach to serving animal health clients worldwide, addressing their full spectrum of legal needs with the goal of enhancing animal health and wellbeing, as well as securing high-quality sources of protein. We draw on our deep industry expertise and understanding of regulators to develop sophisticated strategies for engaging with key authorities, such as the FDA, European Medicines Agency (EMA), European Commission, the UK Veterinary Medicines Directorate (VMD), and China’s National Medical Products Administration (NMPA). We also maintain strong relationships with leading industry bodies, including HealthforAnimals, AnimalHealthEurope, and the National Office of Animal Health (NOAH).
Our highly credible animal health practice is led by Dr. Chris Boyle, a qualified veterinary surgeon and recognised thought leader in the sector, enabling Sidley to support clients in areas such as: promotion of veterinary medicines, commercialisation including discounts and rebate schemes, antitrust/competition law, product recalls, suspension of marketing authorisations by regulators, cross-border and online retail of veterinary medicines, off-label use and compounding, supplementary protection certificates, and regulatory classification of products including borderline issues (e.g. between veterinary medicines, supplements, feeds, medical devices, and pesticides). Our comprehensive practice includes transactional expertise led by Robert Darwin, a prominent M&A, Private Equity, and life sciences lawyer. Robert advises global life sciences corporations and investors on a range of deals, including acquisitions, strategic collaborations, and private equity buyouts. His close collaboration with our regulatory team streamlines due diligence and addresses key regulatory issues for prospective buyers.
Sidley’s Animal Health Legal Forum (AHLF), hosted by our Global Animal Health Practice and Dr Chris Boyle, is a unique network that connects in-house animal health lawyers, regulatory affairs and compliance professionals, and investors. It serves as a platform for discussing the latest industry developments, sharing best practices, and fostering connections within the animal health community.
Syngene International Ltd.
Website: https://www.syngeneintl.com/
Syngene International Ltd. is an innovation focused global discovery, development and manufacturing organisation providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele include world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 5000+ strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speedup time to market and lower the cost of innovation. For more details, visit www.syngeneintl.com.
United Animal Health
Website: http://www.unitedanh.com/
United Animal Health, founded in 1956, is a research-driven company that helps protein producers raise healthier animals to feed a growing world. United Animal Health offers livestock nutrition and health products globally through the United Animal Health or affiliate brands. To learn more, visit UnitedAnH.com.
Event Partners
AB7 Sante
Website: https://www.ab7group.com/en/home
AB7 Santé is a French Veterinary Pharmaceutical Laboratory that has been innovating for over 50 years in the field of Animal Health.
Fully integrated for better agility, AB7 is specialized in research, development, production, quality control, registration and sales of veterinary medicines, generics, OTC, biocides & pet care products for the global market.
With its industrial know-how over 2 certified units in France (GMP) and in the United States (EPA), AB7 is able to address specific manufacturing needs, from small series to large volumes, by ensuring a high level of quality and offering the capacity to adapt manufacturing resources, method and technology.
As a CDMO Company, we offer our partners pharmaceutical and non-pharmaceutical outsourcing activities from development to manufacturing by integrating an innovative, sustainable and responsible approach.
AB7 has continually invested in R&D and production capacities with a constant desire to develop its industrial know-how and to own state-of-the-art equipment for a relevant service in the field of pharmaceutical products within GMP standards. Our 5 R&D Laboratories with more than 45 specialists and our industrial equipments allow us to satisfy the requirements of both small and large pharmaceutical companies within a constructive partnership.
Specialized in exclusive drug delivery systems, AB7 supports its partners in the development of new innovative products and is able to provide full line of products with more traditional galenics.
At AB7, we aim to contribute to today's animal health and welfare challenges by working with international partners to achieve this mission together.
Lawless Strategic Communications
Website: https://www.lawlesscomms.com/
At Lawless Strategic Communications, we're your Corporate Communications experts. With decades of success leading Corporate Communications at top-tier public and private companies, Julie Lawless launched Lawless Strategic Communications in 2022, bringing the Purpose + Passion approach to serve companies in animal health and nutrition, veterinary and food production sectors. From the most complex reputational and brand issues to routine transaction communications, thought leadership, internal engagement and ESG programs, our knowledge and expertise can produce significant results. We understand the industry and quickly work alongside you to enhance and protect your vision - always grounded in your strategy and Purpose. Visit us today to learn more about our approach and how we can help you at www.lawlesscomms.com.
Medfiles
Website: https://medfilesgroup.com/
Medfiles has been supporting its clients on the path of commercialisation in Animal Health for over 15 years. We provide flexible solutions for our clients’ outsourcing needs in areas of R&D and analytical, Regulatory Affairs, Pharmacovigilance and Feed Regulatory.
The Veterinary Medicines Teams of our Regulatory Affairs and Pharmacovigilance units can help you navigate the registration and maintenance processes of medicines smoothly and support our client in post-authorisation activities at both local and global level.
Whilst our Feed Regulatory services can support Feed business operators from product development to launch in Feed Materials and Feed Additives.
If you lack in-house veterinary expertise or resources, Medfiles’ experts are happy to help with projects, both large and small.
Vetio Animal Health
Website: https://vetio.com/
As a Contract Development and Manufacturing Organization (CDMO) dedicated to Animal Health, Vetio integrates product development, analytical services, technical services, and commercial manufacturing of veterinary pharmaceuticals using a Quality-by-Design approach. Vetio is your single-source partner for successful product approval, scale-up, and ongoing commercial supply.
Vetio has provided expertise to animal health companies around the world since 2001 and is committed to the development and manufacturing of products that improve the lives of animals, while assuring the safety, quality and compliance of our products to the highest industry standards.
Ask Us about our intellectual property in pharmaceutical soft chews and palatability. Please visit www.vetio.com and watch our brief company overview video.
Vbiosci
Website: https://www.vbiosci.com/en/
Vbiosci is a Beijing-based biotechnology leader dedicated to revolutionizing animal health through embryo-free and serum-free vaccine development. Our proprietary full-suspension cell culture technology sets a new global standard—delivering higher productivity, lower costs, and reduced contamination risks compared to conventional egg-based or anchorage dependent cell culture methods.
Cutting Edge Process Technologies
l Avian Vaccines
Serum-free, full-suspension manufacturing in large-scale bioreactors maximizes efficiency while eliminating supply chain and safety limitations of embryonated eggs.
Examples include Newcastle Disease (NDV), Infectious Bronchitis (IBV), and Fowl Adenovirus (FAdV) vaccines.
l Livestock Vaccines
Advanced serum-free suspension cell culture platform slashes production costs and contamination risks for broader animal health applications compared to serum dependent and anchorage-dependent processes.
Examples include Pseudo Rabies Virus (PRV), Porcine Circovirus 2 (PCV2), Bovine viral diarrhoea virus (BVDV) vaccines.
World-Class Biotech Infrastructure
l $100M in cumulative investment
l State-of-the-art facilities:
GMP manufacturing compliant with global standards
P2 biosafety-level animal testing labs (pets and livestock)
End-to-end R&D and production capabilities
l Proven Track Record
40+ successful vaccine and monoclonal antibody projects
Approved vaccines in China include AIV & NCD combination vaccine (cell culture-based) and PRV vaccine (serum-free cell culture)
Why Vbiosci?
Breakthrough technology replacing outdated, high-risk production methods
Scalable, cost-efficient solutions for global markets
Validated by regulatory approvals—translating innovation into real-world impact
Vbiosci is a Beijing-based biotechnology leader dedicated to revolutionizing animal health through embryo-free and serum-free vaccine development. Our proprietary full-suspension cell culture technology sets a new global standard—delivering higher productivity, lower costs, and reduced contamination risks compared to conventional egg-based or anchorage dependent cell culture methods.
Cutting Edge Process Technologies
l Avian Vaccines
Serum-free, full-suspension manufacturing in large-scale bioreactors maximizes efficiency while eliminating supply chain and safety limitations of embryonated eggs.
Examples include Newcastle Disease (NDV), Infectious Bronchitis (IBV), and Fowl Adenovirus (FAdV) vaccines.
l Livestock Vaccines
Advanced serum-free suspension cell culture platform slashes production costs and contamination risks for broader animal health applications compared to serum dependent and anchorage-dependent processes.
Examples include Pseudo Rabies Virus (PRV), Porcine Circovirus 2 (PCV2), Bovine viral diarrhoea virus (BVDV) vaccines.
World-Class Biotech Infrastructure
l $100M in cumulative investment
l State-of-the-art facilities:
GMP manufacturing compliant with global standards
P2 biosafety-level animal testing labs (pets and livestock)
End-to-end R&D and production capabilities
l Proven Track Record
40+ successful vaccine and monoclonal antibody projects
Approved vaccines in China include AIV & NCD combination vaccine (cell culture-based) and PRV vaccine (serum-free cell culture)
Why Vbiosci?
Breakthrough technology replacing outdated, high-risk production methods
Scalable, cost-efficient solutions for global markets
Validated by regulatory approvals—translating innovation into real-world impact
Vetoquinol
Website: https://www.vetoquinol.com/en
Founded in 1933, Vetoquinol is the 9th largest veterinary pharmaceutical business, committed to the protection and well-being of both animals and people.